Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ceapro Inc (CZO.VN)

Ceapro Inc (CZO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 18,399
  • Shares Outstanding, K 78,293
  • Annual Sales, $ 18,840 K
  • Annual Income, $ 4,398 K
  • 60-Month Beta 0.90
  • Price/Sales 1.63
  • Price/Cash Flow N/A
  • Price/Book 0.61
Trade CZO.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date 04/10/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

    TSX Bottom 100 Stocks

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.200 +17.50%
on 02/29/24
0.265 -11.32%
on 03/01/24
+0.035 (+17.50%)
since 02/28/24
3-Month
0.150 +56.67%
on 02/06/24
0.265 -11.32%
on 03/01/24
+0.030 (+14.63%)
since 12/28/23
52-Week
0.150 +56.67%
on 02/06/24
0.680 -65.44%
on 03/29/23
-0.415 (-63.85%)
since 03/28/23

Most Recent Stories

More News
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop an Inhalable Immuno-Therapeutic/-Prophylactic for COVID-19-Induced Lung Fibrosis

– Continuation of research with McMaster University to validate the anti-fibrotic properties of the Company’s PGX-Processed yeast beta glucan in...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Inc. Announces Publication of Positive Results for PGX-Processed Alginates Impregnated with CoQ10 in The Journal of Supercritical Fluids

– PGX Technology continues to demonstrate the ability to generate superior novel bioactive delivery systems – Findings from the collaborative project with...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Bolsters Executive Management Team with Appointment of Sigrun Watson as Chief Revenue Officer

Recognized commercial leader with over 20 years of experience across diverse healthcare industries Appointment marks strategic step in driving Company...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Announces Results of 2022 Shareholders’ Meeting

EDMONTON, Alberta, June 07, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference

EDMONTON, Alberta, May 23, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc.  (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update

– Best quarterly financial results in history of the Company – Q1 2022 sales of $6,172,000 vs $4,702,000 in Q1 2021, a 31% increase – Operating profit...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Inc. Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids

PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug delivery and wound healing...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors

Accomplished business executive and attorney with diverse industry experience including over 20 years in life sciences and pharma with successful track...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

– FY 2021 record sales of $17,200,000 compared to $15,100,000 for FY 2020, representing a 14% increase year over year; Ceapro’s best sales performance in...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)
Ceapro Signs Exclusive Long-Term Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise

- Symrise to distribute and commercialize Ceapro’s high value active ingredients in the cosmetic market - - Supply and distribution agreement provides...

CZO.VN : 0.235 (unch)
CRPOF : 0.1669 (-2.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.235
2nd Resistance Point 0.235
1st Resistance Point 0.235
Last Price 0.235
1st Support Level 0.235
2nd Support Level 0.235
3rd Support Level 0.235

See More

52-Week High 0.680
Fibonacci 61.8% 0.478
Fibonacci 50% 0.415
Fibonacci 38.2% 0.352
Last Price 0.235
52-Week Low 0.150

See More

Business Summary

Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar